Back to Results
First PageMeta Content



PRESS RELEASE AbbVie Receives Health Canada Approval of HOLKIRATM PAK for the Treatment of Chronic Genotype 1 Hepatitis C  New all-oral, short-course (12 weeks), interferon-free treatment available in Canada for geno
Add to Reading List

Document Date: 2018-07-18 19:08:19


Open Document

File Size: 328,56 KB

Share Result on Facebook
UPDATE